DeepMed Research

THE BRIGHAM AND WOMEN'S HOSPITAL, INC.

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Smart Phone Delivered Cognitive Behavioral Therapy for Adults with Psoriasis and Co-Morbid Depression Symptoms

Not Applicable

Recruiting

Conditions: Depressive Symptoms
Psoriasis

Interventions: Other: Coach-guided smartphone delivered CBT program.

First Posted Date: 2024-01-22

Last Posted Date: 2024-11-01

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 30

Registration Number: NCT06216691

Locations: 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States

Drug Screening Using IMD in Bladder Cancer

Early Phase 1

Not yet recruiting

Conditions: Muscle Invasive Bladder Urothelial Carcinoma

Interventions: Device: Implantable Micro-Device
Drug: Methotrexate
Drug: Carboplatin
Drug: Avelumab
Drug: Paclitaxel
Drug: Vinblastine
Drug: Gemcitabine/Cisplatin I
Drug: Methotrexate/Vinblastine/Doxorubicin/Cisplatin/Avelumab
Drug: Gemcitabine/Cisplatin II
Drug: Cisplatin
Drug: Nivolumab
Drug: Pembrolizumab
Drug: Gemcitabine/Carboplatin
Drug: Methotrexate/Vinblastine/Doxorubicin/Cisplatin
Drug: Gemcitabine/Cisplatin/Nivolumab
Drug: Erdafitinib
Drug: Paclitaxel/Docetaxel/Ifosfamide
Drug: Gemcitabine
Drug: Gemcitabine/Carboplatin/Nivolumab
Drug: Enfortumab
Drug: Sacituzumab

First Posted Date: 2024-01-12

Last Posted Date: 2024-01-12

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 18

Registration Number: NCT06204614

Locations: 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States

Subclinical Primary Aldosteronism in Diabetes At-Risk for Kidney Disease

Early Phase 1

Recruiting

Conditions: Chronic Kidney Diseases
Type 2 Diabetes

Interventions: Diagnostic Test: Oral sodium suppression test
Diagnostic Test: Saline suppression test
Diagnostic Test: Captopril suppression test
Diagnostic Test: Dexamethasone suppression test
Diagnostic Test: Cosyntropin stimulation test

First Posted Date: 2024-01-05

Last Posted Date: 2025-04-09

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 125

Registration Number: NCT06190158

Locations: 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States

Time-restricted Eating in Peri- and Postmenopausal Women

Not Applicable

Recruiting

Conditions: Obesity
Dyslipidemias
Menopause

Interventions: Behavioral: Time-restricted eating

First Posted Date: 2024-01-03

Last Posted Date: 2024-01-05

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 100

Registration Number: NCT06188598

Locations: 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States

Fremanezumab Treatment of Migraine in Women With Menstrual Migraine Ages 18-45

Phase 4

Recruiting

Conditions: Migraine
Menstrual Migraine
Menstrually Related Migraine

Interventions: Drug: Fremanezumab
Other: Placebo

First Posted Date: 2023-12-18

Last Posted Date: 2024-05-16

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 72

Registration Number: NCT06173661

Locations: 🇺🇸
Brigham and Women's Health Care Center, Chestnut Hill, Massachusetts, United States

Low-Glycemic (LGI) Diet in Pregnant People With Epilepsy

Not Applicable

Not yet recruiting

Conditions: Epilepsy

Interventions: Other: Low Glycemic Index Diet

First Posted Date: 2023-12-18

Last Posted Date: 2023-12-18

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 21

Registration Number: NCT06175247

Locations: 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States

A Positive Psychology Based Intervention (PATH-C) for Caregivers of HSCT Survivors

Not Applicable

Recruiting

Conditions: Hematologic Malignancy
Caregiver

Interventions: Behavioral: PATH-C

First Posted Date: 2023-12-01

Last Posted Date: 2024-05-31

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 80

Registration Number: NCT06153797

Locations: 🇺🇸
Dana Farber Cancer Institute, Boston, Massachusetts, United States

ED90 of Bupivacaine After Lidocaine Test Dose with DPE and EPL

Phase 4

Recruiting

Conditions: Labor Pain

Interventions: Drug: Bupivacaine Hydrochloride

First Posted Date: 2023-11-27

Last Posted Date: 2025-02-10

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 120

Registration Number: NCT06146842

Locations: 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States

Korus: a Device to Prevent Sudden Unexpected Death in Epilepsy (SUDEP)

Not Applicable

Not yet recruiting

Conditions: Epilepsy

Interventions: Device: Control subjects

First Posted Date: 2023-11-18

Last Posted Date: 2023-11-18

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 10

Registration Number: NCT06135285

Locations: 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States

Sonication-based OCD Neurosurgical Intervention Via Capsulotomy

Phase 1

Not yet recruiting

Conditions: Obsessive-Compulsive Disorder

Interventions: Device: ExAblate MR-guided Focused Ultrasound Bilateral Anterior Capsulotomy

First Posted Date: 2023-11-14

Last Posted Date: 2024-08-06

Lead Sponsor: Brigham and Women's Hospital

Target Recruit Count: 66

Registration Number: NCT06131502

Locations: 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
🇺🇸
Stanford University, Palo Alto, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy